Skip to main content
CF PharmTech, Inc. logo

CF PharmTech, Inc. — Investor Relations & Filings

Ticker · 2652 HKEX Manufacturing
Open in API
Filings indexed 80 across all filing types
Latest filing 2026-02-13 Transaction in Own Shar…
Country HK Hong Kong
Listing HKEX 2652

About CF PharmTech, Inc.

https://www.cfpharmtech.com

CF PharmTech, Inc. is a commercial-stage specialty pharmaceutical company specializing in the research, development, manufacturing, and commercialization of complex drug delivery systems, primarily focusing on inhalation technologies. The company develops treatments for major respiratory conditions, including asthma, Chronic Obstructive Pulmonary Disease (COPD), and allergic rhinitis. Its core product platforms encompass Inhalation Dry Powder Inhalers (DPIs), Metered Dose Inhalers (MDIs), inhalation liquid preparations (nebulizers), and nasal sprays. The firm also leverages advanced formulation techniques, such as liposomes, to enhance drug efficacy and delivery.

Recent filings

Filing Released Lang Actions
NEXT DAY DISCLOSURE RETURN
Transaction in Own Shares Classification · 1% confidence The document is a 'Next Day Disclosure Return' filed with the Hong Kong Stock Exchange. It explicitly details the repurchase of shares and changes in treasury shares for CF PharmTech, Inc. This type of filing is specifically designed to report a company's buyback or sale of its own shares, which aligns perfectly with the 'Transaction in Own Shares' (POS) category.
2026-02-13 English
NEXT DAY DISCLOSURE RETURN
Transaction in Own Shares Classification · 1% confidence The document is a 'Next Day Disclosure Return' from the Hong Kong Stock Exchange, which specifically details the repurchase of shares and changes in treasury shares. According to the filing definitions, reports of a company buying back its own shares fall under the 'Transaction in Own Shares' (POS) category.
2026-02-12 English
NEXT DAY DISCLOSURE RETURN
Transaction in Own Shares Classification · 1% confidence The document is a 'Next Day Disclosure Return' filed by CF PharmTech, Inc. with the Hong Kong Stock Exchange. It explicitly details the repurchase of shares and changes in treasury shares, which falls under the category of 'Transaction in Own Shares' (POS). The document follows the standard regulatory format for such disclosures in Hong Kong.
2026-02-11 English
NEXT DAY DISCLOSURE RETURN
Transaction in Own Shares Classification · 1% confidence The document is a 'Next Day Disclosure Return' from the Hong Kong Stock Exchange, which explicitly details the repurchase of shares and changes in treasury shares for CF PharmTech, Inc. This type of filing is specifically used to report a company's buyback or sale of its own shares, which aligns perfectly with the definition of 'Transaction in Own Shares' (POS).
2026-02-10 English
NEXT DAY DISCLOSURE RETURN
Transaction in Own Shares Classification · 1% confidence The document is a 'Next Day Disclosure Return' filed with the Hong Kong Stock Exchange. It explicitly details the repurchase of shares and changes in treasury shares for CF PharmTech, Inc. According to the filing definitions, reports of a company buying back its own shares (share repurchase) fall under the 'Transaction in Own Shares' (POS) category.
2026-02-09 English
NEXT DAY DISCLOSURE RETURN
Transaction in Own Shares Classification · 1% confidence The document is a 'Next Day Disclosure Return' filed with the Hong Kong Stock Exchange. It explicitly details the repurchase of shares and changes in treasury shares for CF PharmTech, Inc. This type of filing is specifically used to report a company's buyback or sale of its own shares, which aligns perfectly with the definition of 'Transaction in Own Shares' (POS).
2026-02-05 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.